Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00391547 · ClinicalTrials.gov registry record · Phase 2

Pilot Efficacy Study to Treat Gingivitis

A Phase 2 study of Gingival Diseases, sponsored by Biomedical Development Corporation.

Completed
Registry status
Phase 2
Development phase
14
Enrollment target
1
Study location

NCT00391547 is a Phase 2 study of Gingival Diseases that has completed, run by Biomedical Development Corporation. The registered enrollment target is 14 participants, below the 74-participant average among 4 other Gingival Diseases trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00391547, a Phase 2 study of Gingival Diseases, has completed, sponsored by Biomedical Development Corporation.

COMPLETED
Registry status
Phase 2
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The primary purpose is to demonstrate the efficacy of a prescription mouthrinse in human subjects for treatment of Gingivitis.

Conditions Studied

Interventions

  • DRUG Frio Oral Rinse

Study Locations (1)

Missouri

  • University of Missouri at Kansas City, School of Dentistry - Kansas City

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2006-10
Est. Completion 2007-01
Phase Phase 2

What the Registry Record Tells You About NCT00391547

The ClinicalTrials.gov registry entry for NCT00391547 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 4 other Gingival Diseases trials with a reported enrollment target (81% lower). The listed sponsor is Biomedical Development Corporation, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gingival Diseases appearing as the primary indexed condition, and to 1 intervention - of which Frio Oral Rinse is the first listed.

NCT00391547 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT00391547 about?

NCT00391547 is a clinical study titled "Pilot Efficacy Study to Treat Gingivitis". The primary purpose is to demonstrate the efficacy of a prescription mouthrinse in human subjects for treatment of Gingivitis.

What is the current status of trial NCT00391547?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2006-10. Estimated completion is 2007-01.

What conditions does trial NCT00391547 study?

This clinical trial studies the following conditions: Gingival Diseases.

What interventions are being tested in trial NCT00391547?

The interventions under investigation include: Frio Oral Rinse (DRUG).

Who is sponsoring clinical trial NCT00391547?

This trial is sponsored by Biomedical Development Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00391547 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingival Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.